Roila, F <br/><br/>
Antiemetic activity of two different high doses and schedules of metoclopramide in dacarbazine-treated cancer patients.  [electronic resource] 

 -  American journal of clinical oncology  Apr 1992 
 - 112-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0277-3732 
<br/><br/><label>Standard No.: </label>10.1097/00000421-199204000-00003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Dacarbazine--adverse effects<br/>Dexamethasone--therapeutic use<br/>Diphenhydramine--therapeutic use<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Male<br/>Melanoma--drug therapy<br/>Methylprednisolone--therapeutic use<br/>Metoclopramide--therapeutic use<br/>Middle Aged<br/>Nausea--chemically induced<br/>Sarcoma--drug therapy<br/>Vomiting--chemically induced